| Rhodopsin (opsin 2, rod pigment) (retinitis pigmentosa 4, autosomal dominant)
|
|
|
| Sensory rhodopsin II (rainbow colored) embedded in a lipid bilayer (heads red and tails blue) with Transducin below it. Gtα is colored red, Gtβ blue, and Gtγ yellow. There is a bound GDP molecule in the Gtα-subunit and a bound retinal (black) in the rhodopsin. The N-terminus terminus of rhodopsin is red and the C-terminus blue. Presumed anchoring of transducin to the membrane has been drawn in black.
|
| Available structures: 1eds, 1edx, 1f88, 1gzm, 1hzx, 1jfp, 1l9h, 1ln6, 1u19, 2g87, 2hpy, 2i35, 2i36, 2i37
|
| Identifiers
|
| Symbol(s)
| RHO; MGC138309; MGC138311; OPN2; RP4
|
| External IDs
| OMIM: 180380 MGI: 97914 Homologene: 68068
|
| Gene Ontology
|
| Molecular Function:
| • rhodopsin-like receptor activity
• receptor activity
|
| Cellular Component:
| • photoreceptor outer segment
• plasma membrane
• integral to plasma membrane
|
| Biological Process:
| • G-protein coupled receptor protein signaling pathway
• visual perception
• phototransduction, visible light
• rhodopsin mediated signaling
• protein-chromophore linkage
• response to stimulus
|
|
| RNA expression pattern
|
|
More reference expression data
|
| Orthologs
|
|
| Human
| Mouse
|
| Entrez
| 6010
| 212541
|
| Ensembl
| ENSG00000163914
| ENSMUSG00000030324
|
| Uniprot
| P08100
| Q8K0D8
|
| Refseq
| NM_000539 (mRNA)
NP_000530 (protein)
| NM_145383 (mRNA)
NP_663358 (protein)
|
| Location
| Chr 3: 130.73 - 130.74 Mb
| Chr 6: 115.9 - 115.9 Mb
|
| Pubmed search
| [1]
| [2]
|
Rhodopsin, also known as visual purple, is expressed in metazoan photoreceptor cells. It is a pigment of the retina that is responsible for both the formation of the photoreceptor cells and the first events in the perception of light. Rhodopsins belong to the class of G-protein coupled receptors. Rhodopsin is extremely sensitive to light, and enables night-vision. Exposed to white light, the pigment immediately bleaches, and it takes about 30 minutes to regenerate fully in humans.
Additional recommended knowledge
Structure
Rhodopsin consists of its protein part called opsin and a reversibly covalently bound cofactor, retinal. The structure of rhodopsin consists of a bundle of seven transmembrane helices that surround the photoreactive chromophore, 11-cis retinal. Retinal, the chromophore portion of rhodopsin, is made in the retina from Vitamin A. Isomerization of 11-cis-retinal into all-trans-retinal by light induces a conformational change in the opsin that activates the associated G protein and triggers a second messenger cascade.
Rhodopsin of the rods most strongly absorbs green-blue light and therefore appears reddish-purple, which is why it is also called "visual purple". It is responsible for the monochromatic vision in the dark.
Several closely related opsins, the photopsins, exist that differ only in a few amino acids and in the wavelengths of light that they absorb most strongly. These pigments are found in the different types of the cone cells of the retina and are the basis of color vision. Humans have three different other opsins beside rhodopsin, with absorption maxima for yellowish-green (photopsin I), green (photopsin II), and bluish-violet (photopsin III) light.
The photoisomerization of rhodopsin has been studied in detail via x-ray crystallography on rhodopsin crystals. A first photoproduct called photorhodopsin forms within 200 femtoseconds after irradiation followed within picoseconds by a second one called bathorhodopsin with distorted all-trans bonds. This intermediate can be trapped and studied at cryogenic temperatures. Several models (a.o. the bicycle-pedal mechanism, hula-twist mechanism) attempt to explain how the retinal group can change its conformation without clashing with the enveloping rhodopsin protein pocket [1] [2] [3].
Rhodopsin and retinal disease
Mutation of the rhodopsin gene is a major contributor to various retinopathies such as retinitis pigmentosa. The disease causing protein generally aggregates with ubiquitin in inclusion bodies, disrupts the intermediate filament network and impairs the ability of the cell to degrade non-functioning proteins which leads to photoreceptor apoptosis [4]. Other mutations on rhodopsin lead to congential stationary night blindness, mainly due to constitutive activation, when the mutations occur around the chromophore binding pocket of rhodopsin (Mendes et al., 2005). Several other pathological states relating to rhodopsin have been discovered including poor post-Golgi trafficing, dysregulative activation, rod outer segment instability and arrestin binding [5].
Microbial rhodopsins
Main article: Bacterial rhodopsins
Some prokaryotes express proton pumps called bacteriorhodopsin, proteorhodopsin, xanthorhodopsin to carry out phototrophy.[6] Like rhodopsin, these contain retinal and have seven transmembrane alpha helices; however they are not coupled to a G protein. Bacterial halorhodopsin is a light-activated chloride pump.[6] Finally, an alga is known to have an opsin that contains its own monolithic light-gated ion channel, channelrhodopsin. While bacteriorhodopsin, halorhodopsin, and channelrhodopsin all have significant sequence homology to one another, they have no detectable sequence identity to G-protein coupled receptor (GPCR) family where rhodopsins belong. Nevertheless, bacterial rhodopsins and GPCR are possibly evolutionary related, based on similarity of their three-dimensional structures. Therefore, they have been assigned to the same superfamily in Structural Classification of Proteins [7]
References
- ^ Crystallographic Analysis of Primary Visual Photochemistry Hitoshi Nakamichi and Tetsuji Okada Angew. Chem. Int. Ed. 2006, 45, 4270 –4273 doi:10.1002/anie.200600595
- ^ Quantum Mechanical Studies on the Crystallographic Model of Bathorhodopsin Marko Schreiber, Minoru Sugihara, Tetsuji Okada, and Volker Buss Angew. Chem. Int. Ed. 2006, 45, 4274 –4277 doi:10.1002/anie.200600585
- ^ The Twisted C11-C12 Bond of the Rhodopsin Chromophores A Photochemical Hot Spot Oliver Weingart J. Am. Chem. Soc. 2007, 129, 10618-10619 doi:10.1021/ja071793t
- ^ Saliba, R., Munro, P., Luthert, P., Cheetham, E. 2002 The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. Journal of Cell Science. 115:2907-2918.
- ^ Mendes, H., van der Spuy, J., Chapple, P., Cheetham, M. 2005. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends in Molecular Medicine. 11:4.
- ^ a b D.A. Bryant & N.-U. Frigaard (Nov 2006). "Prokaryotic photosynthesis and phototrophy illuminated". Trends Microbiol. 14 (11): 488. doi:doi:10.1016/j.tim.2006.09.001.
- ^ http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.g.e.b.html.
Further reading
- Humphries P, Kenna P, Farrar GJ (1992). "On the molecular genetics of retinitis pigmentosa.". Science 256 (5058): 804-8. PMID 1589761.
- Edwards SC (1995). "Involvement of cGMP and calcium in the photoresponse in vertebrate photoreceptor cells.". The Journal of the Florida Medical Association 82 (7): 485-8. PMID 7673885.
- al-Maghtheh M, Gregory C, Inglehearn C, et al. (1993). "Rhodopsin mutations in autosomal dominant retinitis pigmentosa.". Hum. Mutat. 2 (4): 249-55. doi:10.1002/humu.1380020403. PMID 8401533.
- Garriga P, Manyosa J (2002). "The eye photoreceptor protein rhodopsin. Structural implications for retinal disease.". FEBS Lett. 528 (1-3): 17-22. PMID 12297272.
- Mendes HF, van der Spuy J, Chapple JP, Cheetham ME (2005). "Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy.". Trends in molecular medicine 11 (4): 177-85. doi:10.1016/j.molmed.2005.02.007. PMID 15823756.
- Inglehearn CF, Keen TJ, Bashir R, et al. (1993). "A completed screen for mutations of the rhodopsin gene in a panel of patients with autosomal dominant retinitis pigmentosa.". Hum. Mol. Genet. 1 (1): 41-5. PMID 1301135.
- Farrar GJ, Findlay JB, Kumar-Singh R, et al. (1993). "Autosomal dominant retinitis pigmentosa: a novel mutation in the rhodopsin gene in the original 3q linked family.". Hum. Mol. Genet. 1 (9): 769-71. PMID 1302614.
- Robinson PR, Cohen GB, Zhukovsky EA, Oprian DD (1992). "Constitutively active mutants of rhodopsin.". Neuron 9 (4): 719-25. PMID 1356370.
- Fujiki K, Hotta Y, Hayakawa M, et al. (1992). "Point mutations of rhodopsin gene found in Japanese families with autosomal dominant retinitis pigmentosa (ADRP).". Jpn. J. Hum. Genet. 37 (2): 125-32. PMID 1391967.
- Olsson JE, Gordon JW, Pawlyk BS, et al. (1992). "Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa.". Neuron 9 (5): 815-30. PMID 1418997.
- Andréasson S, Ehinger B, Abrahamson M, Fex G (1993). "A six-generation family with autosomal dominant retinitis pigmentosa and a rhodopsin gene mutation (arginine-135-leucine).". Ophthalmic paediatrics and genetics 13 (3): 145-53. PMID 1484692.
- Inglehearn CF, Lester DH, Bashir R, et al. (1992). "Recombination between rhodopsin and locus D3S47 (C17) in rhodopsin retinitis pigmentosa families.". Am. J. Hum. Genet. 50 (3): 590-7. PMID 1539595.
- Fishman GA, Stone EM, Gilbert LD, Sheffield VC (1992). "Ocular findings associated with a rhodopsin gene codon 106 mutation. Glycine-to-arginine change in autosomal dominant retinitis pigmentosa.". Arch. Ophthalmol. 110 (5): 646-53. PMID 1580841.
- Keen TJ, Inglehearn CF, Lester DH, et al. (1992). "Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal attachment site.". Genomics 11 (1): 199-205. PMID 1765377.
- Dryja TP, Hahn LB, Cowley GS, et al. (1991). "Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa.". Proc. Natl. Acad. Sci. U.S.A. 88 (20): 9370-4. PMID 1833777.
- Gal A, Artlich A, Ludwig M, et al. (1992). "Pro-347-Arg mutation of the rhodopsin gene in autosomal dominant retinitis pigmentosa.". Genomics 11 (2): 468-70. PMID 1840561.
- Sung CH, Davenport CM, Hennessey JC, et al. (1991). "Rhodopsin mutations in autosomal dominant retinitis pigmentosa.". Proc. Natl. Acad. Sci. U.S.A. 88 (15): 6481-5. PMID 1862076.
- Jacobson SG, Kemp CM, Sung CH, Nathans J (1991). "Retinal function and rhodopsin levels in autosomal dominant retinitis pigmentosa with rhodopsin mutations.". Am. J. Ophthalmol. 112 (3): 256-71. PMID 1882937.
- Sheffield VC, Fishman GA, Beck JS, et al. (1991). "Identification of novel rhodopsin mutations associated with retinitis pigmentosa by GC-clamped denaturing gradient gel electrophoresis.". Am. J. Hum. Genet. 49 (4): 699-706. PMID 1897520.
See also
Retinylidene protein
| Transmembrane receptor: G protein-coupled receptors |
|---|
| Class A: Rhodopsin like | Acetylcholine (M1, M2, M3, M4, M5) - Adrenergic (α1 (A, B, D), α2 (A, B, C), β1, β2, β3) - Adrenomedullin - Anaphylatoxin (C3a, C5a) - Angiotensin (1, 2) - Apelin - Bile acid - Bombesin (BRS3, GRPR, NMBR) - Bradykinin (B1, B2) - Cannabinoid (CB1, CB2) - Chemokine - Cholecystokinin (A, B) - Dopamine (D1, D2, D3, D4, D5) - Eicosanoid (CysLT (1, 2), LTB4 (1, 2), FPRL1, OXE, Prostaglandin ((DP (1, 2), EP (1, 2, 3, 4), PGF, Prostacyclin, Thromboxane) - EBI2 - Endothelin (A, B) - Estrogen - Formyl peptide (1, L1, L2) - Free fatty acid (1, 2, 3, 4) - FSH - Galanin (1, 2, 3) - Gonadotropin-releasing hormone (1, 2) - GPR (1, 3, 4, 6, 12, 15, 17, 18, 19, 20, 21, 22, 23, 25, 26, 27, 31, 32, 33, 34, 35, 37, 39, 42, 44, 45, 50, 52, 55, 61, 62, 63, 65, 68, 75, 77, 78, 79, 82, 83, 84, 85, 87, 88, 92, 101, 103, 119, 120, 132, 135, 139, 141, 142, 146, 148, 149, 150, 151, 152, 153, 160, 161, 162, 171, 172, 173, 174, 176, 182) - Ghrelin - Histamine (H1, H2, H3, H4) - Kisspeptin - Luteinizing hormone/choriogonadotropin - Lysophospholipid (1, 2, 3, 4, 5, 6, 7, 8) - MAS (1, 1L, D, E, F, G, X1, X2, X3, X4) - Melanocortin (1, 2, 3, 4, 5) - MCHR (1, 2) - Melatonin (1A, 1B)- Motilin - neuromedin (B, U (1, 2)) - Neuropeptide (B/W (1, 2), FF (1, 2), S, Y (1, 2, 4, 5)) - Neurotensin (1, 2) - Opioid (Delta, Kappa, Mu, Nociceptin, but not Sigma) - Olfactory - Opsin (3, 4, 5, 1LW, 1MW, 1SW, RGR, RRH) - Orexin (1, 2) - Oxytocin - Oxoglutarate - PAF - Prokineticin (1, 2) - Prolactin-releasing peptide - Protease-activated (1, 2, 3, 4) - Purinergics (Adenosine (A1, A2a, A2b, A3), P2Y, (1, 2, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14)) - Relaxin (1, 2, 3, 4) - Somatostatin (1, 2, 3, 4, 5) - Serotonin, all but 5-HT3 (5-HT1 (A, B, D, E, F), 5-HT2 (A, B, C), 5-HT (4, 5A, 6, 7)) - SREB - Succinate - TAAR (1, 2, 3, 5, 6, 8, 9) - Tachykinin (1, 2, 3) - Thyrotropin - Thyrotropin-releasing hormone - Urotensin-II - Vasopressin (1A, 1B, 2) |
|---|
| Class B: Secretin like | Brain-specific angiogenesis inhibitor (1, 2, 3) - Cadherin (1, 2, 3) - Calcitonin - CD97 - Corticotropin-releasing hormone (1, 2) - EMR (1, 2, 3) - Glucagon (GR, GIPR, GLP1R, GLP2R) - Growth hormone releasing hormone - PACAPR1- GPR (56, 64, 97, 98, 110, 111, 112, 113, 114, 115, 116, 123, 124, 125, 126, 128, 133, 143, 144, 157) - Latrophilin (1, 2, 3, ELTD1) - Parathyroid hormone (1, 2) - Secretin - Vasoactive intestinal peptide (1, 2) |
|---|
| Class C: Metabotropic glutamate / pheromone | Calcium-sensing receptor - GABA B (1, 2) - Glutamate receptor (Metabotropic glutamate (1, 2, 3, 4, 5, 6, 7, 8)) - GPRC6A - GPR (156, 158, 179) - RAIG (1, 2, 3, 4) - Taste receptors (TAS1R (1, 2, 3) TAS2R (1, 3, 4, 5, 8, 9, 10, 12, 13, 14, 16, 38, 39, 40, 41, 43, 44, 45, 46, 47, 48, 49, 50)) |
|---|
| Frizzled / Smoothened | Frizzled (1, 2, 3, 4, 5, 6, 7, 8, 9, 10) - Smoothened |
|---|
|
